Identification of a ZEB2-MITF-ZEB1 Transcriptional Network That Controls Melanogenesis and Melanoma Progression

Overview

Journal Cell Death Differ

Specialty Cell Biology

Date 2014 Apr 29

PMID 24769727

Citations 119

Authors

G Denecker

N Vandamme

O Akay

D Koludrovic

J Taminau

K Lemeire

A Gheldof

B De Craene

M Van Gele

L Brochez

G M Udupi

M Rafferty

B Balint

W M Gallagher

G Ghanem

D Huylebroeck

J Haigh

J van den Oord

L Larue

I Davidson

J-C Marine

G Berx

Affiliations

Soon will be listed here.

Abstract

Deregulation of signaling pathways that control differentiation, expansion and migration of neural crest-derived melanoblasts during normal development contributes also to melanoma progression and metastasis. Although several epithelial-to-mesenchymal (EMT) transcription factors, such as zinc finger E-box binding protein 1 (ZEB1) and ZEB2, have been implicated in neural crest cell biology, little is known about their role in melanocyte homeostasis and melanoma. Here we show that mice lacking Zeb2 in the melanocyte lineage exhibit a melanoblast migration defect and, unexpectedly, a severe melanocyte differentiation defect. Loss of Zeb2 in the melanocyte lineage results in a downregulation of the Microphthalmia-associated transcription factor (Mitf) and melanocyte differentiation markers concomitant with an upregulation of Zeb1. We identify a transcriptional signaling network in which the EMT transcription factor ZEB2 regulates MITF levels to control melanocyte differentiation. Moreover, our data are also relevant for human melanomagenesis as loss of ZEB2 expression is associated with reduced patient survival.

Citing Articles

Mapping chromatin interactions at melanoma susceptibility loci and cell-type specific dataset integration uncovers distant gene targets of -regulation.

Thakur R, Xu M, Sowards H, Yon J, Jessop L, Myers T medRxiv. 2025; .

PMID: 39802764 PMC: 11722502. DOI: 10.1101/2024.11.14.24317204.

miRNAs Involvement in Modulating Signalling Pathways Involved in Ros-Mediated Oxidative Stress in Melanoma.

Escobar Moreno J, Fajardo Castiblanco J, Riano Rodriguez L, Barrios Ospina P, Zabala Bello C, Munoz Roa E Antioxidants (Basel). 2024; 13(11).

PMID: 39594467 PMC: 11591318. DOI: 10.3390/antiox13111326.

Distinct melanocyte subpopulations defined by stochastic expression of proliferation or maturation programs enable a rapid and sustainable pigmentation response.

Aggarwal A, Nasreen A, Sharma B, Sahoo S, Aswin K, Faruq M PLoS Biol. 2024; 22(8):e3002776.

PMID: 39163475 PMC: 11364419. DOI: 10.1371/journal.pbio.3002776.

Sexual dimorphism in melanocyte stem cell behavior reveals combinational therapeutic strategies for cutaneous repigmentation.

An L, Kim D, Donahue L, Mejooli M, Eom C, Nishimura N Nat Commun. 2024; 15(1):796.

PMID: 38280858 PMC: 10821900. DOI: 10.1038/s41467-024-45034-3.

Differentiation States of Phenotypic Transition of Melanoma Cells Are Revealed by 3D Cell Cultures.

Fontana F, Sommariva M, Anselmi M, Bianchi F, Limonta P, Gagliano N Cells. 2024; 13(2).

PMID: 38247872 PMC: 10814891. DOI: 10.3390/cells13020181.

References

Sanchez-Martin M, Perez-Losada J, Rodriguez-Garcia A, Gonzalez-Sanchez B, Korf B, Kuster W . Deletion of the SLUG (SNAI2) gene results in human piebaldism. Am J Med Genet A. 2003; 122A(2):125-32. DOI: 10.1002/ajmg.a.20345. View

Southall T, Brand A . Neural stem cell transcriptional networks highlight genes essential for nervous system development. EMBO J. 2009; 28(24):3799-807. PMC: 2770102. DOI: 10.1038/emboj.2009.309. View

Ackermann J, Frutschi M, Kaloulis K, McKee T, Trumpp A, Beermann F . Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. Cancer Res. 2005; 65(10):4005-11. DOI: 10.1158/0008-5472.CAN-04-2970. View

Moriyama M, Osawa M, Mak S, Ohtsuka T, Yamamoto N, Han H . Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocyte stem cells. J Cell Biol. 2006; 173(3):333-9. PMC: 2063834. DOI: 10.1083/jcb.200509084. View

MacKenzie M, Jordan S, Budd P, JACKSON I . Activation of the receptor tyrosine kinase Kit is required for the proliferation of melanoblasts in the mouse embryo. Dev Biol. 1998; 192(1):99-107. DOI: 10.1006/dbio.1997.8738. View

Gembarska A, Luciani F, Fedele C, Russell E, Dewaele M, Villar S . MDM4 is a key therapeutic target in cutaneous melanoma. Nat Med. 2012; 18(8):1239-47. PMC: 3744207. DOI: 10.1038/nm.2863. View

Sanchez-Martin M, Rodriguez-Garcia A, Perez-Losada J, Sagrera A, Read A, Sanchez-Garcia I . SLUG (SNAI2) deletions in patients with Waardenburg disease. Hum Mol Genet. 2002; 11(25):3231-6. DOI: 10.1093/hmg/11.25.3231. View

Kubic J, Young K, Plummer R, Ludvik A, Lang D . Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease. Pigment Cell Melanoma Res. 2008; 21(6):627-45. PMC: 2979299. DOI: 10.1111/j.1755-148X.2008.00514.x. View

Steingrimsson E, Copeland N, Jenkins N . Melanocyte stem cell maintenance and hair graying. Cell. 2005; 121(1):9-12. DOI: 10.1016/j.cell.2005.03.021. View

10.

Caramel J, Papadogeorgakis E, Hill L, Browne G, Richard G, Wierinckx A . A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell. 2013; 24(4):466-80. DOI: 10.1016/j.ccr.2013.08.018. View

11.

Jiang R, Lan Y, Norton C, Sundberg J, Gridley T . The Slug gene is not essential for mesoderm or neural crest development in mice. Dev Biol. 1998; 198(2):277-85. View

12.

van de Putte T, Francis A, Nelles L, van Grunsven L, Huylebroeck D . Neural crest-specific removal of Zfhx1b in mouse leads to a wide range of neurocristopathies reminiscent of Mowat-Wilson syndrome. Hum Mol Genet. 2007; 16(12):1423-36. DOI: 10.1093/hmg/ddm093. View

13.

Strub T, Giuliano S, Ye T, Bonet C, Keime C, Kobi D . Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene. 2011; 30(20):2319-32. DOI: 10.1038/onc.2010.612. View

14.

Flaherty K, Puzanov I, Kim K, Ribas A, McArthur G, Sosman J . Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med. 2010; 363(9):809-19. PMC: 3724529. DOI: 10.1056/NEJMoa1002011. View

15.

Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer. 2007; 7(6):415-28. DOI: 10.1038/nrc2131. View

16.

Gupta P, Kuperwasser C, Brunet J, Ramaswamy S, Kuo W, Gray J . The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Genet. 2005; 37(10):1047-54. PMC: 1694635. DOI: 10.1038/ng1634. View

17.

Higashi Y, Maruhashi M, Nelles L, van de Putte T, Verschueren K, Miyoshi T . Generation of the floxed allele of the SIP1 (Smad-interacting protein 1) gene for Cre-mediated conditional knockout in the mouse. Genesis. 2002; 32(2):82-4. DOI: 10.1002/gene.10048. View

18.

Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E . The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell. 2001; 7(6):1267-78. DOI: 10.1016/s1097-2765(01)00260-x. View

19.

Nishimura E, Granter S, Fisher D . Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science. 2004; 307(5710):720-4. DOI: 10.1126/science.1099593. View

20.

Nazarian R, Prieto V, Elder D, Duncan L . Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study. J Cutan Pathol. 2010; 37 Suppl 1:41-7. DOI: 10.1111/j.1600-0560.2010.01505.x. View